BackHomology Medicines Overview

Homology Medicines Current Cash

Homology Medicines's current cash is $110M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$106.27M
93.81% YoYΔ $51.44M vs prior year quarter

Peer trimmed avg / median

Loading

Homology Medicines Current Cash History

Loading

Homology Medicines vs. peers: Current Cash Comparison

Loading

Homology Medicines Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Homology Medicines (FIXX) FAQ

As of the most recent data (June 2026), FIXX shows a current cash of $110M. That compares with $55M in the prior-year period — up 93.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FIXX's current cash is now $110M (was $55M) — a 93.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Homology Medicines is outperforming or lagging.

Tracking FIXX's current cash over time shows whether Homology Medicines is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $55M in the prior-year period — up 93.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Homology Medicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $110M) with ownership activity and broader fundamentals.

Homology Medicines's current cash is $110M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.